Biologics, Cardiovascular Effects and Cancer

BMC Medicine - United Kingdom
doi 10.1186/1741-7015-12-48
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Psoriasis, Cardiovascular Events, and Biologics: Lights and Shadows

Frontiers in Immunology
AllergyImmunology
2018English

AB0313 Cardiovascular Risk, Biologics and Anti-Cyclic Citrullinated Peptide Positivity in Rheumatoid Arthritis

2017English

Orchidectomy Versus Oestrogen for Prostatic Cancer: Cardiovascular Effects.

BMJ
1986English

Cardiovascular and Metabolic Effects of Androgen-Deprivation Therapy for Prostate Cancer

Journal of Oncology Practice
Health PolicyOncology
2018English

Identification and Validation of a Novel Biologics Target in Triple Negative Breast Cancer

Scientific Reports
Multidisciplinary
2019English

Integrated Fluorescent Cytology With Nano-Biologics for Peritoneally Disseminated Gastric Cancer Patients

Cancer Science
Cancer ResearchMedicineOncology
2018English

Transitioning Between Biologics

SKIN The Journal of Cutaneous Medicine
2019English

Molecular Targeted Treatment of Metastatic Colorectal Cancer: The Cardiovascular Adverse Effects of Bevacizumab and Cetuximab

Medicine and Pharmacy Reports
Medicine
2017English

Cardiovascular Effects of Tolazoline and Ranitidine.

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
1987English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy